S&P 500
(0.12%) 5 303.27 points

Dow Jones
(0.34%) 40 004 points

Nasdaq
(-0.07%) 16 686 points

Oil
(-0.10%) $79.98

Gas
(1.37%) $2.66

Gold
(0.87%) $2 438.40

Silver
(4.10%) $32.54

Platinum
(0.94%) $1 100.30

USD/EUR
(-0.02%) $0.920

USD/NOK
(-0.05%) $10.67

USD/GBP
(0.04%) $0.787

USD/RUB
(0.09%) $91.05

Realtime updates for Aurobindo Pharma Limited [AUROPHARMA.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-25)

Expected move: +/- 3.35%

Last Updated18 May 2024 @ 02:59

25% discount on Stockinvest.us - Use code: Podcast

3.66% INR 1 202.40

Live Chart Being Loaded With Signals

Commentary (18 May 2024 @ 02:59):

Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India...

Stats
Today's Volume	415 110
Average Volume	1.72M
Market Cap	704.53B
EPS	INR0 ( 2024-02-11 )
Next earnings date	( INR14.00 ) 2024-05-25
Last Dividend	INR3.00 ( 2023-02-17 )
Next Dividend	INR0 ( N/A )
P/E	25.49
ATR14	INR1.338 (0.11%)

Volume Correlation

Long: -0.10 (neutral)

Short: 0.81 (strong)

Signal:(48.319) Same movement expected

Aurobindo Pharma Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aurobindo Pharma Limited Correlation - Currency/Commodity

0.47
( neutral )

0.31
( neutral )

0.07
( neutral )

0.40
( neutral )

0.37
( neutral )

0.33
( neutral )

Aurobindo Pharma Limited Financials

Annual	2022
Revenue:	INR246.17B
Gross Profit:	INR133.24B (54.12 %)
EPS:	INR32.90

FY	2022
Revenue:	INR246.17B
Gross Profit:	INR133.24B (54.12 %)
EPS:	INR32.90

FY	2022
Revenue:	INR233.67B
Gross Profit:	INR132.26B (56.60 %)
EPS:	INR45.19

FY	2021
Revenue:	INR245.58B
Gross Profit:	INR146.55B (59.68 %)
EPS:	INR91.05

Financial Reports:

No articles found.

Aurobindo Pharma Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Aurobindo Pharma Limited Dividend Information - Dividend Knight

Dividend Sustainability Score: 4.12 - low (37.00%) | Divividend Growth Potential Score: 5.12 - Stable (2.47%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.150	2001-09-12
Last Dividend	INR3.00	2023-02-17
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	42	--
Total Paid Out	INR38.23	--
Avg. Dividend % Per Year	0.47%	--
Score	3	--
Div. Sustainability Score	4.12
Div.Growth Potential Score	5.12
Div. Directional Score	4.62	--

Next Divdend (Est)
(2024-10-01)

INR0 Estimate 0.00 %

Dividend Stability

0.09 Very Bad

Dividend Score

3.00

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2001	INR0	0.00%
2002	INR0	0.00%
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR2.25	0.36%
2019	INR2.50	0.34%
2020	INR4.25	0.93%
2021	INR4.50	0.49%
2022	INR6.00	0.82%
2023	INR3.00	0.69%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
TOUCHWOOD.NS	Dividend Junior	2023-09-22	Annually	6	0.15%
PFC.NS	Dividend King	2023-06-16	Quarterly	18	7.12%
JAGSNPHARM.NS	Dividend Junior	2023-08-21	Annually	22	1.32%
CYIENT.NS	Dividend Knight	2023-06-12	Annually	18	1.81%
SJVN.NS	Dividend Knight	2023-09-21	Semi-Annually	15	4.18%
MBAPL.NS	Dividend Junior	2023-09-18	Annually	8	0.44%
GRSE.NS	Dividend Knight	2023-09-15	Semi-Annually	6	1.43%
BALMLAWRIE.NS	Dividend Knight	2023-09-20	Annually	23	3.62%
PRESSMN.NS	Dividend Knight	2023-07-07	Annually	12	2.06%
KALYANIFRG.NS	Dividend Junior	2023-09-13	Annually	17	0.81%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.100	1.500	7.99	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.101	1.500	9.99	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	15.99	1.000	5.19	5.19	[3 - 30]
operatingCashFlowPerShareTTM	51.10	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	25.58	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.548	1.000	4.20	4.20	[0.2 - 0.8]
operatingProfitMarginTTM	0.148	1.000	9.03	9.03	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.12

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.43	1.000	7.53	0	[1 - 100]
returnOnEquityTTM	0.101	2.50	10.00	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	25.58	2.00	1.474	10.00	[0 - 30]
dividendYielPercentageTTM	0.374	1.500	0.644	0	[0 - 0.4]
operatingCashFlowPerShareTTM	51.10	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	3.80	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.109	1.000	9.79	0	[0.1 - 0.5]
Total Score				5.12

Aurobindo Pharma Limited Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aurobindo Pharma Limited

Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.